About methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate
methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate (PubChem CID 166628265) has the molecular formula C28H29F4N5O5
and a molecular weight of 591.56 g/mol. Its IUPAC name is methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate.
Molecular Properties
| Compound Name | methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate |
| PubChem CID | 166628265 |
| Molecular Formula | C28H29F4N5O5 |
| Molecular Weight | 591.56 g/mol |
| Exact Mass | 591.21 |
| IUPAC Name | methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate |
| SMILES | COC(=O)c1cn(C2CC2)c2cc(N3CCN(CCCNc4ccc([N+](=O)[O-])c(C(F)(F)F)c4)CC3)c(F)cc2c1=O |
| InChI | InChI=1S/C28H29F4N5O5/c1-42-27(39)20-16-36(18-4-5-18)24-15-25(22(29)14-19(24)26(20)38)35-11-9-34(10-12-35)8-2-7-33-17-3-6-23(37(40)41)21(13-17)28(30,31)32/h3,6,13-16,18,33H,2,4-5,7-12H2,1H3 |
| InChIKey | JQJQNSMYWPGAEH-UHFFFAOYSA-N |
| XLogP | 4.81 |
| TPSA | 109.95 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 591.56 |
| LogP ≤ 5 | 4.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate?
The IUPAC name of methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate (CID 166628265) is methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate.
What is the SMILES notation for methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate?
The canonical SMILES for methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate is COC(=O)c1cn(C2CC2)c2cc(N3CCN(CCCNc4ccc([N+](=O)[O-])c(C(F)(F)F)c4)CC3)c(F)cc2c1=O.
What is the InChIKey of methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate?
The InChIKey is JQJQNSMYWPGAEH-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H29F4N5O5/c1-42-27(39)20-16-36(18-4-5-18)24-15-25(22(29)14-19(24)26(20)38)35-11-9-34(10-12-35)8-2-7-33-17-3-6-23(37(40)41)21(13-17)28(30,31)32/h3,6,13-16,18,33H,2,4-5,7-12H2,1H3.
What are the key properties of methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate?
methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate has a molecular weight of 591.56 g/mol, XLogP of 4.81, 9 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 1-cyclopropyl-6-fluoro-7-[4-[3-[4-nitro-3-(trifluoromethyl)anilino]propyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylate is sourced from PubChem (CID 166628265), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).